Nitric oxide in airways of patients with obstructive sleep apnea Source: Eur Respir J 2005; 26: Suppl. 49, 356s Year: 2005
Effect of nasal CPAP on exhaled nitric oxide in patients with obstructive sleep apnea Source: Eur Respir J 2007; 30: Suppl. 51, 332s Year: 2007
Exhaled nitric oxide is not altered in patients with obstructive sleep apnea syndrome Source: Annual Congress 2007 - Airway regulation, provocation and monitoring II Year: 2007
Oral nitric oxide in obstructive sleep apnoea (OSA) Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008
Diurnal variation of exhaled nitric oxide in obstructive sleep apnea syndrome and healthy subjects Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008
Alveolar but not airway fractional exhaled nitric oxide concentration (FENO) is decreased in obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2003; 22: Suppl. 45, 467s Year: 2003
Concentration of exhaled nitric oxide (FENO ) in patients with obstructive sleep apnea Source: Eur Respir J 2004; 24: Suppl. 48, 118s Year: 2004
Nitric oxide and obstructive sleep apnea syndrome (OSAS): reflection of inflammation and oxidative stress Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008
impact of continous positive airway pressure therapy on exhaled nitic oxide in obstructive sleep apnea syndrome Source: International Congress 2019 – Clinical problems from non-malignant pleural disease to hypoventilation Year: 2019
Obstructive sleep apnoea, inspiratory flows and exhaled nitric oxide Source: Eur Respir J 2006; 28: Suppl. 50, 415s Year: 2006
Oxydative stress in obstructive sleep apnea: Value of fractional exhaled nitric oxide measurement Source: International Congress 2018 – Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality Year: 2018
Exhaled nitric oxide in obstructive sleep apnea (OSA) patients: short and long term response to automatic positive airway pressure (APAP) therapy Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007
Decreased plasma levels of nitric oxide (NO) derivatives in obstructive sleep apnea (OSA): response to automatic positive airway pressure (APAP) therapy Source: Eur Respir J 2007; 30: Suppl. 51, 332s Year: 2007
Increased bronchial but not alveolar exhaled nitric oxide is associated with snoring Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008
Interrelationships between oxidative stress and MMP-9 in subjects with severe obstructive sleep apnea syndrome Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea Year: 2016
Nitric oxide metabolites and erythrocyte deformability in a group of subjects with obstructive sleep apnea syndrome Source: International Congress 2014 – Of mice and men: physiology and biology of sleep disordered breathing Year: 2014
Increased alveolar nitric oxide concentration in asthmatic patients with nocturnal symptoms Source: Eur Respir J 2002; 20: 841-845 Year: 2002
The influence of short-term therapy of continous positive airway pressure (CPAP) on exhaled nitric oxide concentration (FENO ) in patients with obstructive sleep apnea (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 357s Year: 2005
Nocturnal symptoms in asthma are related to increased alveolar nitric oxide concentration Source: Eur Respir J 2002; 20: Suppl. 38, 6s Year: 2002
Frequency of obstructive sleep apnea in acute myocardial infarction patients and association with the level of homocystein and nitric oxide Source: Eur Respir J 2006; 28: Suppl. 50, 815s Year: 2006